Clinical trials
Terminated Neoplasms trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oslo University Hospital | 2 |
| AbbVie | 1 |
| Abbott | 1 |
| Bayer | 1 |
| GlaxoSmithKline | 1 |
| Hoffmann-La Roche | 1 |
| Norwegian University of Science and Technology | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 9 |
| Adenocarcinoma | 2 |
| Carcinoma | 2 |
| Head and Neck Neoplasms | 2 |
| Neoplasms by Histologic Type | 2 |
| Neoplasms by Site | 2 |
| Small Cell Lung Carcinoma | 2 |
| Bronchial Diseases | 1 |
| Carcinoma, Bronchogenic | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.